Exane Derivatives Illumina, Inc. Transaction History
Exane Derivatives
- $157 Million
- Q2 2022
A detailed history of Exane Derivatives transactions in Illumina, Inc. stock. As of the latest transaction made, Exane Derivatives holds 2 shares of ILMN stock, worth $299. This represents 0.0% of its overall portfolio holdings.
Number of Shares
2
Previous 61
96.72%
Holding current value
$299
Previous $21,000
100.0%
% of portfolio
0.0%
Previous 0.01%
Shares
14 transactions
Others Institutions Holding ILMN
# of Institutions
876Shares Held
139MCall Options Held
1.42MPut Options Held
1.61M-
Black Rock Inc. New York, NY18.1MShares$2.71 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA15.9MShares$2.38 Billion0.03% of portfolio
-
Baillie Gifford & CO5.61MShares$839 Million0.46% of portfolio
-
State Street Corp Boston, MA5.6MShares$838 Million0.03% of portfolio
-
Loomis Sayles & CO L P4.46MShares$668 Million0.64% of portfolio
About ILLUMINA, INC.
- Ticker ILMN
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 157,300,000
- Market Cap $23.6B
- Description
- Illumina, Inc. provides sequencing and array-based solutions for genetic and genomic analysis. Its products and services serve customers in a range of markets enabling the adoption of genomic solutions in research and clinical settings for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments....